The first demonstration that pharmacologically selective agents could rescue cell surface expression and function of GPCRs, which were otherwise retained in the endoplasmic reticulum, came from work conducted on V2 vasopressin receptor mutants responsible for nephrogenic diabetes insipidus [41], [76], [84]. This evidence concerns the gene AVPR2 and diabetes insipidus.